• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺肿瘤:蛋白质组学研究的新见解

Thyroid tumors: novel insights from proteomic studies.

作者信息

Damante Giuseppe, Scaloni Andrea, Tell Gianluca

机构信息

Dipartimento di Scienze e Tecnologie Biomediche, Piazzale Kolbe 1, 33100 Udine, Italy.

出版信息

Expert Rev Proteomics. 2009 Aug;6(4):363-76. doi: 10.1586/epr.09.51.

DOI:10.1586/epr.09.51
PMID:19681672
Abstract

Several genomics-based techniques have been applied in the last decade to the molecular characterization of cancer, which has led to a variety of applications suitable for improved diagnosis, prognosis and prediction of outcome to treatment. Proteomics-based approaches have also been seen as crucial to the discovery of biomarkers for early diagnosis and prognosis of tumors, as well as for a better understanding of the molecular bases of cancer. Accordingly, proteomic techniques have been used extensively for a better molecular characterization of thyroid tumors. In this field, three main directions have been preceded: first, proteomic studies of model systems; second, proteomics of thyroid tumor specimens; and third, serum proteomics. In this review, we describe the most relevant results that have been obtained for tumors derived from thyroid follicular cells using various proteomic approaches.

摘要

在过去十年中,几种基于基因组学的技术已应用于癌症的分子特征分析,这带来了各种适用于改善癌症诊断、预后和治疗结果预测的应用。基于蛋白质组学的方法也被视为发现肿瘤早期诊断和预后生物标志物以及更好地理解癌症分子基础的关键。因此,蛋白质组学技术已被广泛用于对甲状腺肿瘤进行更好的分子特征分析。在该领域,已出现三个主要方向:第一,模型系统的蛋白质组学研究;第二,甲状腺肿瘤标本的蛋白质组学;第三,血清蛋白质组学。在本综述中,我们描述了使用各种蛋白质组学方法对源自甲状腺滤泡细胞的肿瘤所获得的最相关结果。

相似文献

1
Thyroid tumors: novel insights from proteomic studies.甲状腺肿瘤:蛋白质组学研究的新见解
Expert Rev Proteomics. 2009 Aug;6(4):363-76. doi: 10.1586/epr.09.51.
2
Proteomics: new technologies and clinical applications.蛋白质组学:新技术与临床应用
Eur J Cancer. 2008 Dec;44(18):2737-41. doi: 10.1016/j.ejca.2008.09.007. Epub 2008 Nov 1.
3
Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.甲状腺肿瘤标志物的基因组学和蛋白质组学:诊断和临床意义。
J Cell Physiol. 2010 Sep;224(3):612-9. doi: 10.1002/jcp.22187.
4
Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.通过蛋白质组学发现肝细胞癌新生物标志物
Liver Int. 2007 Mar;27(2):163-73. doi: 10.1111/j.1478-3231.2007.01447.x.
5
Application of proteomics in ovarian cancer: which sample should be used?蛋白质组学在卵巢癌中的应用:应使用哪种样本?
Gynecol Oncol. 2009 Dec;115(3):497-503. doi: 10.1016/j.ygyno.2009.09.005. Epub 2009 Oct 6.
6
Recent advances in clinical oncoproteomics.临床肿瘤蛋白质组学的最新进展
J BUON. 2007 Sep;12 Suppl 1:S31-8.
7
Proteomic approaches for serum biomarker discovery in cancer.用于癌症血清生物标志物发现的蛋白质组学方法。
Anticancer Res. 2007 May-Jun;27(3A):1247-55.
8
Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.甲状腺肿瘤的分子表型分析确定了用于分化型甲状腺癌诊断的标志物组合。
Ann Surg Oncol. 2008 Oct;15(10):2811-26. doi: 10.1245/s10434-008-0034-8. Epub 2008 Jul 9.
9
Proteomic approaches in lung cancer biomarker development.肺癌生物标志物开发中的蛋白质组学方法。
Expert Rev Proteomics. 2009 Feb;6(1):27-42. doi: 10.1586/14789450.6.1.27.
10
Cancer proteomics and its application to discovery of therapy response markers in human cancer.癌症蛋白质组学及其在人类癌症治疗反应标志物发现中的应用。
Cancer. 2006 Jul 15;107(2):232-41. doi: 10.1002/cncr.22000.

引用本文的文献

1
Proteomic Analysis of Tissue Proteins Related to Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌侧方淋巴结转移相关组织蛋白的蛋白质组学分析
J Proteome Res. 2025 Jan 3;24(1):256-267. doi: 10.1021/acs.jproteome.4c00737. Epub 2024 Nov 27.
2
Peptidomics Unveils Distinct Acetylation Patterns of Histone and Annexin A1 in Differentiated Thyroid Cancer.肽组学揭示分化型甲状腺癌中组蛋白和膜联蛋白 A1 的独特乙酰化模式。
Int J Mol Sci. 2023 Dec 27;25(1):376. doi: 10.3390/ijms25010376.
3
Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer.
蛋白质组学揭示了甲状腺癌中的 mRNA 调控和膜联蛋白的作用。
Int J Mol Sci. 2023 Sep 26;24(19):14542. doi: 10.3390/ijms241914542.
4
The Potential of Metabolomics in the Diagnosis of Thyroid Cancer.代谢组学在甲状腺癌诊断中的潜力。
Int J Mol Sci. 2020 Jul 24;21(15):5272. doi: 10.3390/ijms21155272.
5
Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-131I-avid lung metastases.比较血清蛋白质组学分析确定afamin为非131I摄取性肺转移的甲状腺乳头状癌患者中下调的蛋白质。
Nucl Med Commun. 2013 Dec;34(12):1196-203. doi: 10.1097/MNM.0000000000000001.
6
Proteomic profiling of follicular and papillary thyroid tumors.甲状腺滤泡性和乳头状肿瘤的蛋白质组学分析。
Eur J Endocrinol. 2012 Apr;166(4):657-67. doi: 10.1530/EJE-11-0856. Epub 2012 Jan 24.